Cardiopulmonary Stress Testing Systems Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The market is segmented by Product Type (Exercise Testing Systems, Stress ECG, Stress Blood Pressure Monitors, and Others), End-user and Geography

Market Snapshot

cardiopulmonary-stress-testing-systems-market_Market Summary
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: >4.6 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Cardiopulmonary Stress Testing Systems Market studied was anticipated to grow with a CAGR of nearly 4.6%, during the forecast period.  The major factors attributing to the growth are a rise in the global prevalence of multiple cardiovascular indications and atrial fibrillation necessitating the evaluation of Cardiopulmonary functioning. For instance, according to Global Health And Wellness Report - 2018, about 40% of the adult population in the United States have been diagnosed with a cardiovascular condition in 2018 demanding the adoption of stress testing procedures for early diagnosis of heart diseases driving the market growth throughout the forecast period.

Scope of the Report

The cardiopulmonary stress test is an evaluation of the cardiopulmonary system that allows the physician to assess the functioning of the heart and lungs during exercise. The amount of oxygen consumed by the person while riding a bike or walk on a treadmill is used to assess various conditions like dyspnea, hypertrophic cardiomyopathy, and pulmonary hypertension.

Product Type
Stress Blood Pressure Monitors
Exercise Testing Systems
Stress ECG
Others
End-user
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Exercise Testing Systems are Expected to Hold the Largest Market Share

  • The Exercise Testing Systems attributes the largest share in the market owing to the accuracy and the least operating time taken by these devices. Furthermore, the increased preference by the physicians and patients due to their cost-effectiveness and multiple applications of these devices also contribute to the rise in the adoption of these systems fueling the growth of the market.
  • Based on the end-users, the hospital segment is expected to dominate the cardiopulmonary stress testing systems market. Dominance is due to the preference of patients for the early diagnosis of cardiovascular diseases as prescribed by physicians. The diagnostic centers are likely to witness the highest growth due to the adoption of advanced technologies in the developed countries driving the global cardiopulmonary stress testing systems market over the forecast period.
Obese Trends By Country 2016

North America Dominates the Market and Expected to do Same in the Forecast Period.

North America is expected to dominate the global cardiopulmonary stress testing (CPST) systems market throughout the forecast period. The dominance is due to the rising prevalence of cardiovascular and pulmonary disorders such as arrhythmia, heart failures, ischemic heart disease, dyspnea and heart valve imbalance in the United States which generates higher demand for the CPST. For instance, according to the Journal of American Medical Association report - 2018, about 93.3 million adults over the age of 20 in the United States were obese which is the major cause for cardiopulmonary diseases driving the market growth in the forecast period. Also, increasing incidences of lifestyle diseases and enhanced awareness among the medical professionals about the advantages of CPST along with the availability of advanced healthcare infrastructure in the region contributes to its outstanding share in the global market revenue.

CPPPPSSTTT

Competitive Landscape

The cardiopulmonary stress testing systems market is moderately competitive and consists of several major players. In terms of market revenue, few of the prominent players currently dominating the market are vigorously making acquisitions with the other companies to consolidate their market positions across the globe and while others are launching new products. For example, in August 2019, Vyaire Medical Inc received FDA clearance for its two Novel Pulmonary Function Testing Products Vyntus ONE and Vyntus BODY, expanded their existing Vyntus products portfolio which runs on the easy-to-operate SentrySuite Software. The approved products offer a modern ergonomic design, consistent and accurate respiratory testing attracting the attention of customers in the U.S. Healthcare contributing to the market growth. Some of the companies which are currently dominating the market are Koninklijke Philips N V, Hillrom Services Inc, General Electric Company,  MGC Diagnostics Corporation, OSI Systems Inc.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rise in Global Healthcare Expenditure

      2. 4.2.2 Rise in Global Prevalence of Cardiopulmonary Disorders

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent FDA Regulations

      2. 4.3.2 Higher Challenges During the Development Stage and Expensive Testing Procedures

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Product Type

      1. 5.1.1 Stress Blood Pressure Monitors

      2. 5.1.2 Exercise Testing Systems

      3. 5.1.3 Stress ECG

      4. 5.1.4 Others

    2. 5.2 End-user

      1. 5.2.1 Hospitals

      2. 5.2.2 Specialty Clinics

      3. 5.2.3 Ambulatory Surgical Centers

      4. 5.2.4 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 MGC Diagnostics Corporation

      2. 6.1.2 General Electric Company

      3. 6.1.3 Koninklijke Philips N V

      4. 6.1.4 Hill-Rom Holdings Inc

      5. 6.1.5 OSI Systems Inc

      6. 6.1.6 Cosmed Srl

      7. 6.1.7 Cardinal Health

      8. 6.1.8 Care Medical Ltd

      9. 6.1.9 Cardiac Science Corp

      10. 6.1.10 Thermo Fisher Scientific Ltd

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Cardiopulmonary Stress Testing Systems Market market is studied from 2018 - 2026.

The Cardiopulmonary Stress Testing Systems Market is growing at a CAGR of >4.6% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

MGC Diagnostics Corporation, General Electric Company, Koninklijke Philips N V, Hill-Rom Holdings Inc, OSI Systems Inc are the major companies operating in Cardiopulmonary Stress Testing Systems Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!